| Literature DB >> 32755567 |
Yan Liu1, Fleur M Ferguson2, Lianbo Li1, Miljan Kuljanin3, Caitlin E Mills4, Kartik Subramanian4, Wayne Harshbarger1, Sudershan Gondi1, Jinhua Wang2, Peter K Sorger4, Joseph D Mancias3, Nathanael S Gray2, Kenneth D Westover5.
Abstract
Doublecortin-like kinase 1 (DCLK1) is critical for neurogenesis, but overexpression is also observed in multiple cancers and is associated with poor prognosis. Nevertheless, the function of DCLK1 in cancer, especially the context-dependent functions, are poorly understood. We present a "toolkit" that includes the DCLK1 inhibitor DCLK1-IN-1, a complementary DCLK1-IN-1-resistant mutation G532A, and kinase dead mutants D511N and D533N, which can be used to investigate signaling pathways regulated by DCLK1. Using a cancer cell line engineered to be DCLK1 dependent for growth and cell migration, we show that this toolkit can be used to discover associations between DCLK1 kinase activity and biological processes. In particular, we show an association between DCLK1 and RNA processing, including the identification of CDK11 as a potential substrate of DCLK1 using phosphoproteomics.Entities:
Keywords: cancer; doublecortin-like kinase 1; kinase inhibitor; mass spectrometry; phosphoproteomics; signal transduction; structural biology
Year: 2020 PMID: 32755567 PMCID: PMC8053042 DOI: 10.1016/j.chembiol.2020.07.011
Source DB: PubMed Journal: Cell Chem Biol ISSN: 2451-9448 Impact factor: 8.116